A. Atalla, M. Garnica, A. Maiolino, and M. Nucci, Risk factors for invasive mold diseases in allogeneic hematopoietic cell transplant recipients, Transpl Infect Dis, vol.17, pp.7-13, 2015.

N. Harrison, M. Mitterbauer, and S. Tobudic, Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study, BMC Infect Dis, vol.15, pp.584-592, 2015.

R. Herbrecht, P. Bories, J. C. Moulin, M. P. Ledoux, and V. Letscher-bru, Risk stratification for invasive aspergillosis in immunocompromised patients, Ann N Y Acad Sci, vol.1272, pp.23-30, 2012.

J. M. Shi, X. Y. Pei, and Y. Luo, Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years, J Zhejiang Univ Sci B, vol.16, pp.796-804, 2015.

D. Neofytos, D. Horn, and E. Anaissie, Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry, Clin Infect Dis, vol.48, pp.265-273, 2009.

J. W. Baddley, Clinical risk factors for invasive aspergillosis, Med Mycol, vol.49, issue.1, pp.7-12, 2011.

D. P. Kontoyiannis, K. A. Marr, and B. J. Park, Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, Clin Infect Dis, vol.50, pp.1091-1100, 2001.

O. Lortholary, J. P. Gangneux, and K. Sitbon, Epidemiological trends in invasive aspergillosis in France: the SAIF network, Clin Microbiol Infect, vol.17, pp.1882-1889, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00680990

C. Garcia-vidal, U. A. Kirby, K. A. Marr, and K. A. , Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation, Clin Infect Dis, vol.47, pp.1041-1050, 2008.

K. A. Marr, R. A. Carter, M. Boeckh, P. Martin, and L. Corey, Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors, Blood, vol.100, pp.4358-4366, 2002.

R. Kojima, M. Kami, and Y. Nannya, Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen, Biol Blood Marrow Transplant, vol.10, pp.645-652, 2004.

D. P. Kontoyiannis, G. Chamilos, and R. E. Lewis, Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation, Cancer, vol.110, pp.1303-1306, 2007.

A. A. Panackal, H. Li, and D. P. Kontoyiannis, Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation, Clin Infect Dis, vol.50, pp.1588-1597, 2010.

T. Fukuda, M. Boeckh, and R. A. Carter, Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning, Blood, vol.102, pp.827-833, 2003.

J. A. Hol, T. F. Wolfs, and M. B. Bierings, Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients, Bone Marrow Transplant, vol.49, pp.95-101, 2014.

C. Junghanss, K. A. Marr, and R. A. Carter, Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study, Biol Blood Marrow Transplant, vol.8, pp.512-520, 2002.

A. C. Labbe, S. H. Su, and M. Laverdiere, High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation, Biol Blood Marrow Transplant, vol.13, pp.1192-1200, 2007.

L. Li, J. Wang, and W. Zhang, Risk factors for invasive mold infections following allogeneic hematopoietic stem cell transplantation: a single center study of 190 recipients, Scand J Infect Dis, vol.44, pp.100-107, 2012.

C. N. Mihu, E. King, and O. Yossepovitch, Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation, Transpl Infect Dis, vol.10, pp.162-167, 2008.

K. Thursky, G. Byrnes, A. Grigg, J. Szer, and M. Slavin, Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation, Bone Marrow Transplant, vol.34, pp.115-121, 2004.

P. Zhang, E. L. Jiang, and D. L. Yang, Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a singleinstitution experience, Transpl Infect Dis, vol.12, pp.316-321, 2010.

F. Baron, A. Ruggeri, and E. Beohou, RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT, Oncotarget, vol.7, pp.43027-43038, 2016.

J. R. Passweg, H. Baldomero, and M. Bregni, Hematopoietic SCT in Europe: data and trends in 2011, Bone Marrow Transplant, vol.48, pp.1161-1167, 2013.

B. N. Savani, M. Labopin, and N. Kroger, Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT, Haematologica, vol.101, pp.773-780, 2016.

S. Ascioglu, J. H. Rex, and B. De-pauw, Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus, Clin Infect Dis, vol.34, pp.7-14, 2002.

B. De-pauw, T. J. Walsh, and J. P. Donnelly, Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ MSG) Consensus Group, Clin Infect Dis, vol.46, pp.1813-1821, 2008.

H. Glucksberg, R. Storb, and A. Fefer, Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors, Transplantation, vol.18, pp.295-304, 1974.

A. J. Ullmann, J. H. Lipton, and D. H. Vesole, Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease, N Engl J Med, vol.356, pp.335-347, 2007.

Y. Benjamini and . Hy, Controlling the false discovery rate. A practical and powerful approach to multiple testing, Stat Soc B, vol.57, pp.289-300, 1995.

E. Von-elm, D. G. Altman, and M. Egger, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting of observational studies

, Internist (Berl), vol.49, pp.688-693, 2008.

W. B. Grow, J. S. Moreb, and D. Roque, Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital, Bone Marrow Transplant, vol.29, pp.15-19, 2002.

A. Bergeron, R. Porcher, and A. Sulahian, The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies, Blood, vol.119, pp.1831-1837, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00818508

C. Cordonnier, F. Botterel, B. Amor, and R. , Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis, Clin Microbiol Infect, vol.15, pp.81-86, 2009.

D. Garcia-hermoso, A. Alanio, and O. Cabaret, High diversity of non-sporulating moulds in respiratory specimens of immunocompromised patients: should all the species be reported when diagnosing invasive aspergillosis?, Mycoses, vol.58, pp.557-564, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-01405227

P. Y. Bochud, J. W. Chien, and K. A. Marr, Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation, N Engl J Med, vol.359, pp.1766-1777, 2008.

C. Cunha, F. Aversa, and J. F. Lacerda, Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation, N Engl J Med, vol.370, pp.421-432, 2014.

P. L. White, C. Parr, and R. A. Barnes, Predicting invasive aspergillosis in hematology patients by combining clinical and genetic risk factors with early diagnostic biomarkers, J Clin Microbiol, vol.56, issue.1, pp.1122-1139, 2017.